Cargando…

Redox Imbalance in CD4+ T Cells of Relapsing-Remitting Multiple Sclerosis Patients

As a prevalent autoimmune disease of the central nervous system in young adults, multiple sclerosis (MS) is mediated by T cells, particularly CD4+ subsets. Given the evidence that the perturbation in reactive oxygen species (ROS) production has a pivotal role in the onset and progression of MS, its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tavassolifar, Mohammad Javad, Moghadasi, Abdorreza Naser, Esmaeili, Behnaz, Sadatpour, Omid, Vodjgani, Mohammad, Izad, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735833/ https://www.ncbi.nlm.nih.gov/pubmed/33354282 http://dx.doi.org/10.1155/2020/8860813

Ejemplares similares

The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis
por: Tavassolifar, Mohammad javad, et al.
Publicado: (2020)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

New insights into extracellular and intracellular redox status in COVID-19 patients
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2022)

Redox imbalance in Crohn's disease patients is modulated by Azathioprine
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2021)

The Association of EBV and HHV-6 Viral Load with Different NK and CD8(+) T Cell Subsets in The Acute Phase of Relapsing-Remitting Multiple Sclerosis
por: Salehi, Zahra, et al.
Publicado: (2021)

Clinical effectiveness and safety of fingolimod in relapsing remitting multiple sclerosis in Western Iran
por: Ouspid, Elham, et al.
Publicado: (2018)

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
por: Doosti, Rozita, et al.
Publicado: (2021)

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Headache in relapse and remission phases of multiple sclerosis: A case-control study
por: Togha, Mansoureh, et al.
Publicado: (2016)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Encephalopathy associated with COVID-19 in a patient with multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis
por: Jafari, Zahra, et al.
Publicado: (2018)

The co-occurrence of multiple sclerosis and Evans syndrome: A case report
por: Salehizadeh, Saeideh, et al.
Publicado: (2020)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
por: Moghadasi, Abdorreza Naser
Publicado: (2021)

Economic sanctions against Iran as an important factor in threatening the health of patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2021)

Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region
por: Maghbooli, Zhila, et al.
Publicado: (2020)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2023)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Implementing coronavirus disease 2019 scale-up registry protocol in national multiple sclerosis registry system of Iran
por: Eskandarieh, Sharareh, et al.
Publicado: (2021)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
por: Paybast, Sepideh, et al.
Publicado: (2022)

Can multiple sclerosis as a cognitive disorder influence patients’ dreams?
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

Attitudes toward vaccination in patients with multiple sclerosis: A report from Iran
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Cerebral air emboli
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The contribution of self-disclosure to the prediction of mood symptoms in patients with multiple sclerosis
por: Mahboobi, Marzieh, et al.
Publicado: (2021)

Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
por: Rezaee, Mehdi, et al.
Publicado: (2022)

Can pulse steroid therapy increase the risk of infection by COVID-19 in patients with multiple sclerosis?
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2021)

Epidemiology of multiple sclerosis in Qom: Demographic study in Iran
por: Rezaali, Saeed, et al.
Publicado: (2013)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dq0hcf4gc2noa1jbjhkht1hrts